Kontafarma China Holdings Ltd (HK:1312)
:1312
Want to see HK:1312 full AI Analyst Report?
Total Valuation
Kontafarma China Holdings Ltd has a market cap or net worth of HK$167.36M. The enterprise value is HK$304.98M.
Market CapHK$167.36M
Enterprise ValueHK$304.98M
Share Statistics
Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,588,572,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kontafarma China Holdings Ltd’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -6.14%.
Return on Equity (ROE)-0.77
Return on Assets (ROA)-0.40
Return on Invested Capital (ROIC)-6.14%
Return on Capital Employed (ROCE)-0.07
Revenue Per Employee1.28M
Profits Per Employee-636.88K
Employee Count714
Asset Turnover0.86
Inventory Turnover4.41
Valuation Ratios
The current PE Ratio of Kontafarma China Holdings Ltd is ―. Kontafarma China Holdings Ltd’s PEG ratio is -0.00081.
PE Ratio―
PS Ratio0.18
PB Ratio0.29
Price to Fair Value0.29
Price to FCF3.04
Price to Operating Cash Flow2.35
PEG Ratio-0.00081
Income Statement
In the last 12 months, Kontafarma China Holdings Ltd had revenue of 914.71M and earned -427.85M in profits. Earnings per share was -0.08.
Revenue914.71M
Gross Profit513.64M
Operating Income-44.90M
Pretax Income-454.73M
Net Income-427.85M
EBITDA-14.32M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was 71.12M and capital expenditures -23.52M, giving a free cash flow of 47.59M billion.
Operating Cash Flow71.12M
Free Cash Flow47.59M
Free Cash Flow per Share<0.01
Dividends & Yields
Kontafarma China Holdings Ltd pays an annual dividend of HK$0.004, resulting in a dividend yield of ―
Dividend Per ShareHK$0.004
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change3.45%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)46.74
Average Volume (3m)9.95M
Important Dates
Kontafarma China Holdings Ltd upcoming earnings date is Aug 31, 2026, TBA (Confirmed).
Last Earnings DateMar 27, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
Kontafarma China Holdings Ltd as a current ratio of 0.79, with Debt / Equity ratio of 36.81%
Current Ratio0.79
Quick Ratio0.59
Debt to Market Cap0.86
Net Debt to EBITDA-9.61
Interest Coverage Ratio-4.17
Taxes
In the past 12 months, Kontafarma China Holdings Ltd has paid 27.83M in taxes.
Income Tax27.83M
Effective Tax Rate-0.06
Enterprise Valuation
Kontafarma China Holdings Ltd EV to EBITDA ratio is -20.90, with an EV/FCF ratio of 5.63.
EV to Sales0.33
EV to EBITDA-20.90
EV to Free Cash Flow5.63
EV to Operating Cash Flow3.90
Balance Sheet
Kontafarma China Holdings Ltd has HK$66.06M in cash and marketable securities with HK$203.68M in debt, giving a net cash position of -HK$137.62M billion.
Cash & Marketable SecuritiesHK$66.06M
Total DebtHK$203.68M
Net Cash-HK$137.62M
Net Cash Per Share-HK$0.02
Tangible Book Value Per ShareHK$0.04
Margins
Gross margin is 56.15%, with operating margin of -4.91%, and net profit margin of -46.77%.
Gross Margin56.15%
Operating Margin-4.91%
Pretax Margin-49.71%
Net Profit Margin-46.77%
EBITDA Margin-1.57%
EBIT Margin-4.91%
Analyst Forecast
The average price target for Kontafarma China Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1.92%
EPS Growth Forecast-468.15%